| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |